Effects of cysteamine on nociception in mice

Acta Pharmacologica Sinica

Volumn 22, Issue 7, 2001, Pages 603-608

  Capasso, A ^a   Loizzo, A ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Analgesics; Cysteamine; Pain measurement

Indexed keywords

MERCAPTAMINE; MORPHINE; NALOXONE; OPIATE RECEPTOR; SOMATOSTATIN; ANALGESIC AGENT; ANALGESICS, NON NARCOTIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; TAIL FLICK TEST; ANIMAL; DRUG EFFECT; NOCICEPTIVE RECEPTOR;

ANALGESICS, NON-NARCOTIC; ANIMAL; CYSTEAMINE; MALE; MICE; NALOXONE; NOCICEPTORS; PAIN THRESHOLD; SOMATOSTATIN;

EID: 0034954730     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pantethine and cysteamine deplete cystine from cystinotic fibroblast via efflux of cysteamine-cysteine mixed disulfide
2. Acetaminophen-induced hepatic injur protective role of glutathione in man and rationale for therapy
3. Cystinosis: Intracellular cystine depletion by aminothiols in vitro and in vivo
4. Somatostatin in rat tissue is depleted by cysteamine administration
5. Selective depletion of somatostatin in rat brain by cysteamine
6. Immunoreactivity in the rat cysteamine
7. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord
8. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors
9. Cysteamine-induced depletion of central somatostatin-like immunoactivity: Effects on behavior, learning, memory and brain neurochemistry
10. The effects of cysteamine and capsaicin on somatostatin and substance P in medullary nuclei
11. The effects of cysteamine on thyrotropin and immunoreactive β-endorphin secretion in the rat
12. Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes
13. Depletion of bovine pituitary prolactin by cisteamine involves a thiol: Disulfide mechanism
14. Mechanism and kinetics of the inhibition of dopamine-beta-hydroxylase by 2-mercaptoethylguanidine
15. Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin
16. Effects induced by cysteamine on chemically-induced nociception in mice
17. Effect of somatostatin and its antagonist on morphine analgesia in mice
18. Effects of cysteamine on pain behaviour and on somatostatin- and substance P-like immunoreactivity in the substantia gelatinosa of the rat
19. Somatostatin antagonist analog increase GH, insulin and glucagon release in the rat
20. Ethical guidelines for investigation of experimental pain in conscious animals
21. Synthetic analgesic II, dithienylbutenyl and dithienylbuthylamines
22. The interaction of peripherally and centrally administered dexamethasone and RU 38486 on morphine analgesia in mice
23. A method for determining loss of pain sensation
24. Central interaction of dexamethasone and Ru-38486 on morphine antinociception in mice
25. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
26. Roles of μ, δ and κ opioid receptors in spinal and supraspinal medication of gastrointestinal transit effects and hot-plate analgesia in the mouse
27. Intrathecal morphine in mice: A new technique
28. Narcotic analgetics: CNS sites and mechanism of action as revealed by intracerebral injection tecniques
29. Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat
30. Spinal pain suppression mechanisms may differ for phasic and tonic pain
31. Multiple opioid system and pain
32. The regional distribution of somatostatin in the rat brain
33. Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat
34. Immunohistochemical studies of peptidergic neurons in the dorsal horn of the spinal cord
35. Depressant acions of and somatostatin in cat dorsal horn neurons activated by noxious stimuli
36. Differential release of substance P and somatostatin in the rat spinal cord in response to noxious cold and heat: Effect of dynorphin A(1-17)
37. Opiate-like naloxone-reversible actions of somatostatin given intracerebrally
38. Antinociceptive and neurotoxic actions of somatostatin in rat spinal cord after administration
39. Distinguishable effects of intrathecal dynorphins, somatostatin, neurotensin and s-calcitonin on nociception, and motor function in the rat
40. Somatostatin, a potent analgesic
41. Cysteamine induces a loss of tissue somatostatin-28 when measured as somatostatin-(15-28)-like immunoreactivity but not when assesed as somatostatin-28 (1-14)-like immunoreactivity: Evidence for the importance of the disulfide bond for cysteamine action
42. Effect of local injection of cysteamine and cystamine on somatostatin and neuropeptide Y levels in the rat striatum
43. Opiate antagonistic properties of an octapeptide somatostain analog